Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.
Target Price
The average target price of HTFL is 40 and suggests 27% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell